Cita APA (7a ed.)

Chaudhary, P., Guragain, D., Chang, J., & Kim, J. (2021). TPH1 and 5-HT₇ Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG.

Cita Chicago Style (17a ed.)

Chaudhary, Prakash, Diwakar Guragain, Jae-Hoon Chang, y Jung-Ae Kim. TPH1 and 5-HT₇ Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.

Cita MLA (8a ed.)

Chaudhary, Prakash, et al. TPH1 and 5-HT₇ Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.